Scientists Find How Common Virus May Trigger MS

Scientists at the University of California San Francisco just uncovered how one of the world's most common viruses might trigger multiple sclerosis, and the discovery could unlock treatments for dozens of other diseases too.

The Epstein-Barr virus lives quietly in 95 percent of adults, best known for causing "kissing disease" or mono. But researchers have long suspected this sneaky virus does something far more serious: it may wake up years later and trick the immune system into attacking the brain's own nerve fibers, causing MS.

The UCSF team studied 13 people with MS and compared them to 5 people without the disease. They found something remarkable: specialized immune cells called killer T cells were up to 100 times more abundant around the brain and spinal cord in MS patients, and these cells were specifically hunting for Epstein-Barr virus.

Even more telling, most MS patients had active Epstein-Barr genes in their cerebrospinal fluid. One gene was switched on only in MS patients, not in people without the disease who also carried the virus.

The discovery builds on a 2022 study of 10 million people that found the risk of MS jumps 32 times higher after an Epstein-Barr infection. No other virus showed any connection at all.

Dr. Joe Sabatino, a neurologist on the research team, explains that these findings "connect a lot of different dots and give us a new window on how EBV is likely contributing to this disease."

The Ripple Effect

The implications stretch far beyond multiple sclerosis. Epstein-Barr flare-ups have been linked to lupus, certain cancers, schizophrenia, long COVID, chronic fatigue syndrome, and dementia.

If scientists can figure out how to interfere with this virus, they could potentially help millions of people suffering from all these conditions. The virus is proving to be a key player in far more diseases than anyone previously imagined.

Researchers are already working on the first vaccine candidate against Epstein-Barr, which has shown promising early results. Combined with this new understanding of how the virus operates, treatments that target this immune response could become reality within years.

Understanding what triggers MS has eluded scientists for decades, but this research offers genuine hope for prevention and treatment strategies that seemed impossible just a few years ago.